Figure 4.
circ_0003204 silencing alleviates ox-LDL-resulted HUVECs injury by regulating miR-942-5p. HUVECs were introduced with si-circ_0003204#1 or/and miR-942-5p inhibitor, followed by treatment with 100 mg/L ox-LDL. Cell viability (A), apoptosis (C), and the levels of PCNA and Bax (B,D) were assessed via CCK-8, flow cytometry and western blot assays. (E-G) MDA level, SOD activity and ROS formation were examined by commercial kits. (H-J) The levels of inflammatory cytokines were measured by ELISA. Data were presented as mean ± SD, n = 3. *P < 0.05, **P < 0.01, and ***P < 0.001.